TIF 1st Global Forum on Access to Safe Blood Products for Patients in Need of Regular Transfusion

The 1st Global Forum on Access to Safe Blood Products for Patients in Need of Regular Transfusion, organised by the Thalassemia International Federation (TIF)  took place on 5 November 2021. The aim of the Global Forum is to address gaps outside and within Europe with regards to blood adequacy, and safety. Following this first edition, the Global Forum will meet annually, with the overall objective to ensure access and adequacy of blood supplies for transfusion dependent hemoglobinopathy patients. The event report will be available soon here.

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center